Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following ...

Percutaneous cryoablation yields outcomes comparable to robotic surgery for renal cancer, at significantly lower cost, Danish ...

To maximize the probability of IDE approval, Vivos has engaged John Smith , a regulatory expert with over 25 years of direct experience guiding brachytherapy and combination radiotherapy devices ...

Merck Foundation Chairman and Chief Executive Officer (CEO) together with African First Ladies released “Ray of Hope” ...

Paras Health Srinagar Leads Cancer Awareness And Early Detection Efforts In J & K. Paras Health Srinagar Leads Cancer Awareness and Early Detection Efforts in J&K Srinagar- Paras Health Srinagar host ...

The global interventional radiology (IR) market is poised for significant expansion, projected to grow from USD 30,336.0 ...

Three abstracts to be presented at the 101st Annual Meeting of the Western Section of the American Urological Association, including baseline characteristics and demographics for patients enrolled in ...

According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1 billion in 2025 and is projected to ...

Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high tumor burden (> 25%). Baseline demographics were well-matched between the ...

Objective: This study aimed to evaluate the role of vascular interventional techniques in the management of recurrent nasopharyngeal carcinoma as part of a multidisciplinary treatment framework.

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...